Table 3.
Univariate and multivariate analysis for lymph node count in patients undergoing distal gastrectomy
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| B value | p value | B value (95% CI) | p value | |
| Sex (M/F) | 1.278 | 0.072 | N.A. | N.A. |
| Age [y] (≤65/> 65) | − 1.225 | 0.080 | N.A. | N.A. |
| Neoadjuvant therapy (N/Y) | 4.444 | < 0.001 | 3.562 (1.178,5.947) | 0.003 |
| Tumor size [cm] (≤3/> 3) | 3.381 | < 0.001 | 1.947 (0.353,3.540) | 0.017 |
| T stage (T≤2/T3–4) | 2.863 | < 0.001 | −1.419 (−3.722,0.884) | 0.227 |
| Lymphovascular emboli (N/Y) | 1.231 | 0.084 | N.A. | N.A. |
| Perineural invasion (N/Y) | 2.377 | 0.001 | 0.871 (−0.830,2.572) | 0.316 |
| Tumor deposit (N/Y) | 1.959 | 0.182 | N.A. | N.A. |
| pN stage (N0/N+) | 3.474 | < 0.001 | 1.528 (− 0.460,3.516) | 0.132 |
| M stage (M0/M1) | 0.123 | 0.950 | N.A. | N.A. |
| AJCC stage (I/II-IV) | 3.854 | < 0.001 | 2.073 (−0.755,4.900) | 0.151 |
| Extent of lymphadenectomy (D1+/D2) | 3.248 | < 0.001 | 0.037 (−1.995,2.068) | 0.972 |
| Microsatellite status (MSS/MSI-H) | 2.720 | 0.005 | 2.468 (0.563,4.374) | 0.011 |
CI confidence interval
N.A. not applicable
MSI-H microsatellite instability-high
MSS microsatellite stability